Dr Sibille will be presenting at the Longevity Summit 2024
The Longevity Summit creates a peer to peer learning environment focused on the…
Innovation in Cognitive Pathology - Interview of Dr. Sibille at the annual meeting of the American Psychiatry Association
***Extracted from HCP Live*** Etienne Sibille, PhD: Innovations in Cognitive…
New Review in Trends in Pharmacological Sciences - GABAA receptors as targets for treating affective and cognitive symptoms of depression
A neuroactive steroid (NAS) targeting δ-GABAA receptors has been approved for…
Krembil Foundation Grant awarded to Drs. Sibille and Tomoda
“Targeting Reduced BDNF/TrkB-Mediated Neuroplasticity in Brain Disorders” PI:…
We Are Hiring - PostDoc with Cell Culture Experience
Position Summary: Reduced brain cell structure and function contribute to…
A new grant for studying the role of elevated MAOA in depression and its treatment.
Congratulations to Dr Sibille and collaborators (Drs Meyer, Banasr, Tomoda,…
New Research Article - Reduced inhibition in depression impairs stimulus processing in human cortical microcircuits
Through a multicentered collaboration, joining experts from the Centre for…
Living With Dementia - Dr. Sibille presents how his work can help (CTV Your Morning)
LIVING WITH DEMENTIA - CTV Your Morning Link…
What could prevent suicide? - Read the piece about CAMH research from TORONTO STAR
What could prevent suicide? For CAMH and mental health advocates, it’s advances…
New Review - From serendipity to rational drug design in brain disorders: in silico, in vitro, and in vivo approaches
In this review, the authors provides an overview on the current state of drug…